Can the Lambre Device Occlude IRRegular And Large Appendages in Patients With Non-Valvular AF

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The primary objective is to demonstrate the safety and efficacy of the implantation of the LAmbre PlusTM device in patients with large or irregularly shaped appendages with non-valvular atrial fibrillation who are at increased risk for stroke and systemic embolism compared to oral anticoagulation (OAC).
Epistemonikos ID: bb6b61bdb31a1cac8dafa0c57103ed7f00bb00d4
First added on: May 08, 2024